Arxada to invest $20.8m in ingredient production to aid DSM partnership expansion

Published: 25-Aug-2022

The investment will help the partership by increasing niacin and other nutritional ingredients provided to DSM’s vitamin and aroma business in Visp-Laden

Swiss chemical specialists Arxada has confirmed the extension of its long-term collaboration with Royal DSM (DSM).

As part of the partnership, Arxada will invest $20.8m (CHF 20m) in its production facility in Visp. This investment will be used to expand production lines at the site and increase Arxada's output of nutritional ingredients supplied to DSM.

Antje Gerber, President, Speciality Products Solutions, Arxada, said: "We are delighted to be extending our agreement with DSM and building on the longstanding, mutually beneficial partnership with our neighbours in the Swiss Valais canton."

Like this story? Subscribe to Nutraceutical Business Review magazine for incisive analysis, the latest news and expert-written articles from the functional food and drink industries. For more information click here.

Arxada will also make further investments to reduce the carbon footprint of the Visp site to help meet the sustainability commitments of both companies. This follows Arxada's significant investment in Visp in 2021 to reduce other greenhouse gas emissions at the site.

Gerber added: "This significant new investment in our Visp facility secures the site's long term future, helping to fuel our future growth. It also demonstrates our clear commitment to sustainability and reducing our carbon footprint.

You may also like